Effect of galcanezumab following treatment cessation in patients with migraine: results from 2 randomized phase 3 trials

VL Stauffer, S Wang, M Voulgaropoulos… - … : The Journal of …, 2019 - Wiley Online Library
Objective We examined the efficacy and safety of galcanezumab after treatment cessation in
randomized double‐blind, placebo‐controlled, migraine prevention studies (EVOLVE‐1; …
被引用次数：49 相关文章

Effect of Galcanezumab Following Treatment Cessation in Patients With Migraine: Results From 2 Randomized Phase 3 Trials.

VL Stauffer, S Wang, M Voulgaropoulos, V Skljarevski… - Headache, 2019 - europepmc.org
Effect of Galcanezumab Following Treatment Cessation in Patients With Migraine: Results From
2 Randomized Phase 3 Trials. - Abstract - Europe PMC Sign in | Create an account …

Effect of Galcanezumab Following Treatment Cessation in Patients With Migraine: Results From 2 Randomized Phase 3 Trials.

VL Stauffer, S Wang… - … : The Journal of …, 2019 - search.ebscohost.com
Objective: We examined the efficacy and safety of galcanezumab after treatment cessation
in randomized double‐blind, placebo‐controlled, migraine prevention studies (EVOLVE‐1; …
[HTML] nih.gov

[HTML][HTML] Effect of Galcanezumab Following Treatment Cessation in Patients With Migraine: Results From 2 Randomized Phase 3 Trials

VL Stauffer, S Wang, M Voulgaropoulos, V Skljarevski… - Headache, 2019 - ncbi.nlm.nih.gov
Effect of Galcanezumab Following Treatment Cessation in Patients With Migraine: Results
From 2 Randomized Phase 3 Trials - PMC Back to Top Skip to main content NIH NLM Logo …

Effect of Galcanezumab Following Treatment Cessation in Patients With Migraine: Results From 2 Randomized Phase 3 Trials

VL Stauffer, S Wang, M Voulgaropoulos… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Objective We examined the efficacy and safety of galcanezumab after treatment cessation in
randomized double-blind, placebo-controlled, migraine prevention studies (EVOLVE-1; …